Form 8-K - Current report:
SEC Accession No. 0001689813-21-000092
Filing Date
2021-05-11
Accepted
2021-05-10 21:54:12
Documents
14
Period of Report
2021-05-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20210505.htm   iXBRL 8-K 48731
  Complete submission text file 0001689813-21-000092.txt   190287

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20210505.xsd EX-101.SCH 2441
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20210505_cal.xml EX-101.CAL 722
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20210505_def.xml EX-101.DEF 1655
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20210505_lab.xml EX-101.LAB 23938
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20210505_pre.xml EX-101.PRE 12646
7 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20210505_htm.xml XML 10689
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 21909456
SIC: 2834 Pharmaceutical Preparations